These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24574544)

  • 1. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.
    Moradi H; Streja E; Kashyap ML; Vaziri ND; Fonarow GC; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2014 Aug; 29(8):1554-62. PubMed ID: 24574544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum Triglyceride to HDL Cholesterol Ratio with All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients.
    Chang TI; Streja E; Soohoo M; Kim TW; Rhee CM; Kovesdy CP; Kashyap ML; Vaziri ND; Kalantar-Zadeh K; Moradi H
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):591-602. PubMed ID: 28193609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse Association Between Serum Non-High-Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis.
    Chang TI; Streja E; Ko GJ; Naderi N; Rhee CM; Kovesdy CP; Kashyap ML; Vaziri ND; Kalantar-Zadeh K; Moradi H
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29886420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increments in serum high-density lipoprotein cholesterol over time are not associated with improved outcomes in incident hemodialysis patients.
    Chang TI; Streja E; Soohoo M; Ko GJ; Rhee CM; Kovesdy CP; Kashyap ML; Vaziri ND; Kalantar-Zadeh K; Moradi H
    J Clin Lipidol; 2018; 12(2):488-497. PubMed ID: 29456130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study.
    Ko DT; Alter DA; Guo H; Koh M; Lau G; Austin PC; Booth GL; Hogg W; Jackevicius CA; Lee DS; Wijeysundera HC; Wilkins JT; Tu JV
    J Am Coll Cardiol; 2016 Nov; 68(19):2073-2083. PubMed ID: 27810046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum non-high-density lipoprotein cholesterol (non-HDL-C) levels and cardiovascular mortality in chronic hemodialysis patients.
    Echida Y; Ogawa T; Otsuka K; Ando Y; Nitta K
    Clin Exp Nephrol; 2012 Oct; 16(5):767-72. PubMed ID: 22374049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum lipids and survival in hemodialysis patients and impact of race.
    Kilpatrick RD; McAllister CJ; Kovesdy CP; Derose SF; Kopple JD; Kalantar-Zadeh K
    J Am Soc Nephrol; 2007 Jan; 18(1):293-303. PubMed ID: 17167113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
    Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
    Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study.
    Bansal N; McCulloch CE; Rahman M; Kusek JW; Anderson AH; Xie D; Townsend RR; Lora CM; Wright J; Go AS; Ojo A; Alper A; Lustigova E; Cuevas M; Kallem R; Hsu CY;
    Hypertension; 2015 Jan; 65(1):93-100. PubMed ID: 25287404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of High-Density Lipoprotein Cholesterol Levels on Overall Survival and Major Adverse Cardiovascular and Cerebrovascular Events.
    Kaur M; Ahuja KR; Khubber S; Zhou L; Verma BR; Meenakshisundaram C; Gad MM; Saad A; Dhaliwal K; Isogai T; Rajeswaran J; Toth A; Chahine J; Cho L; Puri R; Kapadia S
    Am J Cardiol; 2021 May; 146():8-14. PubMed ID: 33535058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.
    Nishizawa Y; Shoji T; Kakiya R; Tsujimoto Y; Tabata T; Ishimura E; Nakatani T; Miki T; Inaba M
    Kidney Int Suppl; 2003 May; (84):S117-20. PubMed ID: 12694324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.
    Silbernagel G; Genser B; Drechsler C; Scharnagl H; Grammer TB; Stojakovic T; Krane V; Ritz E; Wanner C; März W
    J Am Soc Nephrol; 2015 Feb; 26(2):484-92. PubMed ID: 25012163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-high-density lipoprotein cholesterol and mortality among peritoneal dialysis patients.
    Yu J; Xia X; Lin T; Huang N; Qiu Y; Yang X; Mao H; Chen W; Huang F
    J Clin Lipidol; 2021; 15(5):732-742. PubMed ID: 34312083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients.
    Chiang CK; Ho TI; Hsu SP; Peng YS; Pai MF; Yang SY; Hung KY; Tsai TJ
    Blood Purif; 2005; 23(2):134-40. PubMed ID: 15665509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies.
    Zhong GC; Huang SQ; Peng Y; Wan L; Wu YQ; Hu TY; Hu JJ; Hao FB
    Eur J Prev Cardiol; 2020 Jul; 27(11):1187-1203. PubMed ID: 32283957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very high high-density lipoprotein cholesterol is associated with increased all-cause mortality in South Koreans.
    Oh IH; Hur JK; Ryoo JH; Jung JY; Park SK; Yang HJ; Choi JM; Jung KW; Won YJ; Oh CM
    Atherosclerosis; 2019 Apr; 283():43-51. PubMed ID: 30776703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of Patients on Hemodialysis and Predictors of Mortality: a Single-Centre Analysis of Time-Dependent Factors.
    Ossareh S; Farrokhi F; Zebarjadi M
    Iran J Kidney Dis; 2016 Nov; 10(6):369-380. PubMed ID: 27903996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein cholesterol and causes of death in chronic kidney disease.
    Navaneethan SD; Schold JD; Walther CP; Arrigain S; Jolly SE; Virani SS; Winkelmayer WC; Nally JV
    J Clin Lipidol; 2018; 12(4):1061-1071.e7. PubMed ID: 29699917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients.
    Postorino M; Marino C; Tripepi G; Zoccali C;
    Kidney Int; 2011 Apr; 79(7):765-72. PubMed ID: 21178980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
    Boden WE; Miller MG; McBride R; Harvey C; Snabes MC; Schmidt J; McGovern ME; Fleg JL; Desvigne-Nickens P; Anderson T; Kashyap M; Probstfield JL
    Am Heart J; 2020 Jun; 224():65-76. PubMed ID: 32335402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.